Neogen Corporation · NASDAQ:NEOG

Neogen — Q1 2024 Earnings Presentation

11 slides from Neogen's earnings presentation, Oct 10, 2023

  1. Slide 1: Fiscal Year 2024 First-Quarter Results

    Fiscal Year 2024 First-Quarter Results October 10, 2023 ©2020 NEOGEN Corporation. All rights reserved.

  2. Slide 2: Disclaimer

    Disclaimer Preliminary Results and Forward-Looking Statements The Company’s reported results are preliminary. The Company has not yet completed its year-end reporting process, and the Company’s independent auditor has not completed its audit. Accordingly, final results and other disclosures to be in

  3. Slide 3: Q1 FY24 Summary

    Q1 FY24 Summary • Revenue broadly in line with expectations outside of Asia, with low-single-digit pro forma core growth achieved in rest of world • Core revenue in combined Food Safety business grew mid-single-digits outside of Asia, including positive volume ‒ Legacy Food Safety business performed

  4. Slide 4: Financial Highlights

    Financial Highlights Adjusted Net Income Revenue ($M) Adjusted EBITDA ($M) ($M, excl. per share) $229.0 $23.7 $52.4 $17.6 $132.3 $27.0 $0.16 $0.11 22.9% Adjusted Adjusted 20.4% Margin (2) EPS EPS (2) Margin Q1 FY23 Q1 FY24 Q1 FY23 Q1 FY24 Q1 FY23 Q1 FY24 • Gross margin expansion of 400 • Adjusted Ne

  5. Slide 5: Balance Sheet & Capital Allocation

    Balance Sheet & Capital Allocation Debt Profile Gross Debt $900M • Net debt roughly flat from Q4, despite elevated capex Less: Cash & • Capex elevated to support integration of former 3M Marketable Securities $239M Food Safety business 33% • $100M of debt repaid since closing of Food Safety Net Debt

  6. Slide 6: FY24 Outlook

    FY24 Outlook • Maintaining full-year outlook – Demand environment generally aligned with expectations, including initial Q2 observations – Historical revenue seasonality implies ~52% in the second half of the year, in addition to moderating compare • Revenue: $955 million – $985 million – Reflects s

  7. Slide 7: Summary

    Summary • Progressing on track towards Q3 integration milestones • Q4 improvements in Petrifilm supply continuity at transition manufacturing partner sustained during Q1 • Focused demand-generation actions being executed, supported by more reliable transition supply • Benefits of combined commercial

  8. Slide 8: Thank you for joining us.

    To view the earnings press release and presentation, visit: Thank you for WWW.NEOGEN.COM/INVESTOR-RELATIONS joining us. 8 ©2023 NEOGEN Corporation. All rights reserved.

  9. Slide 9: Appendix

    Appendix

  10. Slide 10: Non-GAAP Reconciliations: Adjusted EBITDA

    Non-GAAP Reconciliations Adjusted EBITDA 10 ©2023 NEOGEN Corporation. All rights reserved.

  11. Slide 11: Non-GAAP Reconciliations: Adjusted Net Income

    Non-GAAP Reconciliations Adjusted Net Income 11 ©2023 NEOGEN Corporation. All rights reserved.

Neogen — Q1 2024 Earnings Presentation on 6ix